Yeben Qian

469 total citations
24 papers, 334 citations indexed

About

Yeben Qian is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Yeben Qian has authored 24 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Yeben Qian's work include Liver Disease Diagnosis and Treatment (4 papers), Cell Adhesion Molecules Research (4 papers) and Cancer Mechanisms and Therapy (3 papers). Yeben Qian is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Cell Adhesion Molecules Research (4 papers) and Cancer Mechanisms and Therapy (3 papers). Yeben Qian collaborates with scholars based in China and Poland. Yeben Qian's co-authors include Jianlin Zhang, Xiaohu Zheng, Yanhong Ren, Haiming Wei, Zhigang Tian, Lixin Zhu, Binqing Fu, Rui Sun, Wei Dai and Dongyao Wang and has published in prestigious journals such as Hepatology, ACS Applied Materials & Interfaces and Medicine.

In The Last Decade

Yeben Qian

23 papers receiving 332 citations

Peers

Yeben Qian

HEPAT

ONCOL

Liye Tao China

Zhi‐Bo Zhang China

Shaohan Wu China

Xuzhen Yan China

Fangfang Bu China

Simon Milette Canada

Sebastian A. Wohlfeil Germany

Alessio Grimaldi Italy

Marzena Swiderska‐Syn United States

Ai‐Min Xu China

Liye Tao China

Yeben Qian

170 ×1.1

124 ×1.3

93 ×1.4

HEPAT

31 ×0.5

59 ×1.1

ONCOL

Citations per year, relative to Yeben Qian Yeben Qian (= 1×) peers Liye Tao

Countries citing papers authored by Yeben Qian

Since Specialization

Citations

This map shows the geographic impact of Yeben Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeben Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeben Qian more than expected).

Fields of papers citing papers by Yeben Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeben Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeben Qian. The network helps show where Yeben Qian may publish in the future.

Co-authorship network of co-authors of Yeben Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Yeben Qian. A scholar is included among the top collaborators of Yeben Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeben Qian. Yeben Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, Liping, et al.. (2025). Targeting Liver Fibrosis with Nanoparticle Technology: The Dual-Drug Strategy for Hepatic Stellate Cell Activation Inhibition. ACS Applied Materials & Interfaces. 17(17). 25071–25082.

Tao, Ye, Hongni Wang, Yao Peng, et al.. (2025). Ceramide kinase suppresses ferroptosis and protects against alcohol-associated liver disease through the p38 MAPK–HSPB1 pathway. Hepatology Communications. 9(7). 1 indexed citations

Zhang, Tao, Lixin Zhu, Qikai Sun, Lijian Chen, & Yeben Qian. (2024). CARD9 promotes cholangiocarcinoma by regulating the IL-17A/Hedgehog and the THEM4/AKT/mTOR signaling pathways. International Immunopharmacology. 143(Pt 2). 113399–113399. 1 indexed citations

Liu, Muziying, Chenwen Zhu, Huimin Zhang, et al.. (2023). Regulatory mucosa-associated invariant T cells controlled by β1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression. Hepatology. 78(1). 72–87. 18 indexed citations

Zhang, Huimin, Chenxi Tian, Shiyu Bai, et al.. (2023). Antigen Priming Induces Functional Reprogramming in iNKT Cells via Metabolic and Epigenetic Regulation: An Insight into iNKT Cell-Based Antitumor Immunotherapy. Cancer Immunology Research. 11(12). 1598–1610. 2 indexed citations

Wang, Xuben, et al.. (2023). Macrophage-Derived MMP-9 and MMP-2 are Closely Related to the Rupture of the Fibrous Capsule of Hepatocellular Carcinoma Leading to Tumor Invasion. Biological Procedures Online. 25(1). 8–8. 14 indexed citations

Shen, Yiqing, Xiaohu Zheng, Yeben Qian, et al.. (2023). Interactions between driver genes shape the signaling pathway landscape and direct hepatocellular carcinoma therapy. Cancer Science. 114(6). 2386–2399. 8 indexed citations

Zhang, Yong‐Wei, et al.. (2021). Immune infiltrating cells in cholangiocarcinoma may become clinical diagnostic markers: based on bioinformatics analysis. World Journal of Surgical Oncology. 19(1). 59–59. 7 indexed citations

Zhang, Xun, et al.. (2021). Association between socioeconomic status and survival in patients with hepatocellular carcinoma. Cancer Medicine. 10(20). 7347–7359. 17 indexed citations

10.

Yang, Jiazhao, et al.. (2021). Robot-assisted vs freehand cannulated screw placement in femoral neck fractures surgery. Medicine. 100(20). e25926–e25926. 2 indexed citations

11.

Jiang, Yong, Xiaohu Zheng, Defeng Jiao, et al.. (2019). Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma. EBioMedicine. 40. 422–431. 11 indexed citations

12.

Wang, Dongyao, Xiaohu Zheng, Binqing Fu, et al.. (2019). Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling. EBioMedicine. 46. 119–132. 66 indexed citations

13.

Zhang, Jianlin, Jin Huang, Xingyu Wang, et al.. (2017). CMIP is oncogenic in human gastric cancer cells. Molecular Medicine Reports. 16(5). 7277–7286. 14 indexed citations

14.

Dai, Wei, et al.. (2016). Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell. BMC Cancer. 16(1). 45–45. 40 indexed citations

15.

Zhang, Jianlin, et al.. (2014). Talin-1 Correlates with Reduced Invasion and Migration in Human Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention. 15(6). 2655–2661. 26 indexed citations

16.

Zhang, Jianlin, et al.. (2011). Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas.. PubMed. 12(12). 3265–9. 25 indexed citations

17.

Qian, Yeben, Zhigang Liu, & Xiaoping Geng. (2008). Lack of Protection of Ischaemic Preconditioning in the Rat Model of Major Hepatectomy With Ischaemia Reperfusion Injury. Asian Journal of Surgery. 31(3). 140–147. 4 indexed citations

18.

Cai, Ming, et al.. (2007). Additive Immunosuppressive Effect of Hydroxycamptothecin and Cyclosporine on Rejection of Heart Transplantation in Rats. Transplantation Proceedings. 39(10). 3429–3431. 1 indexed citations

19.

Qian, Yeben. (2002). Multivariate regression analysis on early mortality after orthotopic liver transplantion. World Journal of Gastroenterology. 8(1). 128–128. 23 indexed citations

20.

Qian, Yeben, Guihua Chen, & Jiefu Huang. (2002). [Treatment of organ transplant rejection with low doses of CsA and CTLA4-Ig].. PubMed. 40(2). 150–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact